.png)
.png)
Report Library
View More
Datamonitor Healthcare I&I: Thyroid...
June 11, 2021
Datamonitor Healthcare CV&Met: Isch...
June 11, 2021
Datamonitor Healthcare CV&Met: Cold...
June 11, 2021
Datamonitor Healthcare CNS: Fragile...
June 10, 2021
Datamonitor Healthcare Other: Endom...
June 10, 2021
Datamonitor Healthcare Oncology: Me...
June 10, 2021
Datamonitor Healthcare Infectious D...
June 9, 2021
Datamonitor Healthcare CV&Met: Coro...
June 9, 2021
Datamonitor Healthcare CNS: Hunting...
June 9, 2021
Datamonitor Healthcare I&I: Primary...
June 8, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 6/10/21 | Bristol Myers Squibb (BMY) | Breyanzi for Diffuse Large B-Cell Lymphoma (DLBCL) - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/7/21 | Calithera Biosciences (CALA) | Telaglenastat for Renal Cell Cancer (RCC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/7/21 | Biogen (BIIB) | Aduhelm for Alzheimer's Disease (AD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/6/21 | Novartis (NVS) | Iptacopan for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/6/21 | Iovance Biotherapeutics (IOVA) | LN-144 for Melanoma | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 06/11/21 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/11/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 06/11/21 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/12/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
